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Abstract:  Surface-associated marine bacteria often produce secondary metabolites with 
antagonistic  activities.  In  this  study,  tropodithietic  acid  (TDA)  was  identified  to  be 
responsible for the antibacterial activity of the marine epiphytic bacterium Pseudovibrio sp. 
D323 and related strains. Phenol was also produced by these bacteria but was not directly 
related to the antibacterial activity. TDA was shown to effectively inhibit a range of marine 
bacteria  from  various  phylogenetic  groups.  However  TDA-producers  themselves  were 
resistant  and  are  likely  to  possess  resistance  mechanism  preventing  autoinhibition.  We 
propose that TDA in isolate D323 and related eukaryote-associated bacteria plays a role in 
defending  the  host  organism  against  unwanted  microbial  colonisation  and,  possibly, 
bacterial pathogens. 
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1. Introduction 
Ever since the discovery of penicillin there have been many attempts to find novel antimicrobials 
due to the inevitable development of bacterial resistance towards the widely used antibiotics. In the 
past  the  vast  majority  of  natural  product  research  focused  on  terrestrial  sources.  Nowadays,  the 
exploration of new and under-explored sources becomes extremely important in the process of finding 
biologically active compounds (“bioactives”) that can be used as new antibiotics [1]. In recent years 
microorganisms associated with the surfaces of marine eukaryotes have been major targets for the 
discovery  of  new  bioactive  metabolites  [2,3].  This  is  primarily  due  to  the  notion  that  both 
microorganisms  and  hosts  have  developed  a  range  of  chemical  defence  strategies  for  the  fiercely 
competitive  environment  in  which  they  reside  [2–4].  One  such  microbe  that  has  pronounced 
antibacterial  activity  is  the  bacterial  strain  D323,  recently  isolated  from  the  temperate  red  alga 
Delisea pulchra [5,6]. 
The present study aimed to (1) establish the phylogenetic diversity of isolate D323 and closely 
related bacteria; (2) identify the causative compound responsible for the antibacterial activity; and  
(3) assess the spectrum of activity of the antibacterial compound in relation to the possible ecological 
role for its production. 
2. Results and Discussion 
2.1. Isolate D323 Is a Representative of a Widespread, Surface-Associated Alphaproteobacteria Clade 
Phylogenetic  analysis  of  16S  rRNA  gene  sequence  of  isolate  D323  revealed  that  it  is  
an  Alphaproteobacterium  belonging  to  the  family  Rhodobacteraceae,  with  the  species 
Pseudovibrio ascidiaceicola  being  the  closest  fully  described  relative  (99%  identity  with  the  type 
strain, Genbank/EMBL/DDBJ Acc. #AB175663) [7] (Figure 1). In contrast to P. ascidiaceicola, which 
grows as smooth brown-green colonies, isolate D323 form flat brown mucoid colonies when grown on 
Marine Agar (Difco 2216) and resembles that of isolate MBIC3368 and related sponge-associated 
bacteria, to which it has 98% identity in the 16S rRNA gene sequence [8–10] (Figure 1). Antimicrobial 
production  was  reported  for  another  Pseudovibrio  related  to  P.  denitrificans,  strain  Z143-1;  the 
compound was identified as heptylprodigiosin [11]. Moreover, the colony morphology of that strain, 
which  was  reported  to  form  red  colonies  while  producing  the  bioactive  compound,  differed 
significantly from the above-mentioned colony morphology of isolate D323 and MBIC3368 related 
bacteria [8–10]. Antibacterial compounds are likely to be produced by yet other Pseudovibrio species 
as Geng and Belas (2010) recently identified genes encoding for the production of the antibacterial 
compound tropodithietic acid (TDA) in strain Pseudovibrio sp. strain JEO62, which forms a distinct 
clade from D323 [12] (Figure 1). Mar. Drugs 2011, 9  
 
 
1393 
Figure  1.  Maximum  likelihood  phylogenetic  tree  based  on  16S  rRNA  gene  sequence 
showing  the  isolates  used  in  this  study  (in  bold)  and  their  close  neighbours  from 
GenBank/EMBL/DDB  related  to  isolate  D323.  Maximum  parsimony  bootstrap  values 
(1000  resamplings)  are  given  for  major  nodes.  The  scale  bar  indicates  the  number  of 
substitutions per nucleotide position. 
 
Bacterial isolates related to Pseudovibrio sp. D323 have previously been reported to be associated 
with  different  marine  sponges  in  various  geographical  regions  [10,13,14]  and  not  detected  in  the 
surrounding seawater [9], suggesting possible host specificity. Moreover, it has been suggested that 
these bacteria play an important role in host defence against disease as they were found to be present in 
healthy sponges but absent in diseased individuals [9,15]. In addition, Enticknap et al. [9] demonstrated 
that the D323-related bacterium NW001 could be vertically transferred from the parent sponge to the 
offspring,  further  emphasizing  its  importance  for  the  host.  Despite  reports  showing  antibacterial 
activity in some D323-related isolates [10,16], earlier attempts to chemically identify the bioactive 
compound/s produced by these bacteria were not successful [10]. 
2.2. Identification of Antibacterial Secondary Metabolites in D323 and Related Strains 
Given the widespread occurrence of the D323-related sequences and their suggested importance for 
the host, as well as the potential for new drug discovery, the identification of its antibacterial activity 
was of great interest. The antibacterial activity was found in the spent medium of the liquid culture of 
Pseudovibrio sp. D323. Analysis of the Pseudovibrio sp. D323 crude extract by GC-MS identified 
phenol  as  a  major  component  by  both  specific  fragmentation  pattern  and  a  GC  retention  time  
(5.608 min) for the alleged phenol peak in the crude extract which matched that of standard made with 
phenol  (Figure  2).  However,  as  shown  by  TLC  and  TLC-BOA,  the  position  of  the  halo,  which 
corresponded to the position of antibacterial compound, was different from the position of phenol Mar. Drugs 2011, 9  
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(Figure  3a,b)  suggesting  that  the  antibacterial  activity,  observed  in  Pseudovibrio  sp.  D323  crude 
extract, was not due to phenol. 
Further  purification  and  subsequent  chemical  analysis  of  the  active  fraction  using  LC-MS  and  
NMR identified the presence of tropodithietic acid (TDA, up to 1.6 mg/L of spent medium) [17,18] 
(Figure 4). TDA is a known antimicrobial compound produced by Phaeobacter inhibens and related 
strains within the Roseobacter clade [18–21]. Our data correlates with the recent prediction of TDA 
production in other Pseudovibrio strains based on the presence of homologs to the biosynthetic genes 
(tdaA–tdaF), which were also found to be positively regulated in the presence of TDA producers [12]. 
Figure  2.  GC-MS  analysis  of  isolate  D323  crude  extract  (a)  and  corresponding  MS 
spectrum of phenol (b) Identical masses are indicated by dashed arrows, the mass of the 
parental molecule (phenol) is indicated by the red arrow. Data was collected from m/z 45  
to 105. 
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To confirm that D323-related strains indeed produce TDA, crude  extracts of sponge-associated 
isolates, CCSH21, CCSH24, NW001, as well as a known TDA producer, P. inhibens were assessed 
via TLC. The TLC profile of CCSH21, CCSH24 and NW001 were identical to Pseudovibrio sp. D323 
(Figure 3c,d), also showing the presence of phenol. In contrast to Pseudovibrio sp. D323, no phenol 
was detected either in P. inhibens or the TDA-deficient mutant P. inhibens T5-3 grown in the same 
medium (Figure 3c,d). This data correlates with a recent report showing the absence of phenol in 
P. inhibens cultures grown in MB medium, while only trace amounts of phenol were observed in the 
medium supplemented with phenylacetic acid [22]. The production of TDA was evident by the zone of 
inhibition in TLC-BOA, in all the crude  extracts of isolates  grown in  MB, with the  exception of 
P. inhibens  T5-3  (Figure  3).  Phenol  production  was  observed  in  all  the  isolates  related  to 
Pseudovibrio sp. D323 and was not detected in P. inhibens (Figure 3c,d). The presence of phenol 
and/or TDA was confirmed by HPLC (data not shown). 
Figure  3. Results of TLC (T), TLC-BOA (T-B) of crude ethylacetate extract (CE), of 
isolate D323 (323), CCSH21 (21); CCSH24 (24); NW001; P. inhibens T5 (T5) and its 
TDA-deficient  mutant  P.  inhibens  T5-3  (T5-3)  grown  in  MB  (a–d);  as  well  as  of  the 
fractions F1-F6 obtained via the fractionation of the crude extract of isolate D323 (a, b). 
The  ethylacetate  extract  of  acidified  MB  medium  (MB)  and  phenol  (P,  0.1  mg/mL  in 
ethylacetate, Sigma) were used as controls. The red arrow indicates the position of phenol 
on the TLC plate after developing it in ethylacetate:hexane (5:1) mixture. 
 
a  b 
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Figure 4. Molecular structure of 1 (tropodithietic acid) and NMR spectroscopic data (ppm) 
of 1 in comparison to published data by Liang, 2003 [17]. 
13C experiments were obtained 
in d6-DMSO, 
1H experiments were obtained in benzene-d6 on a Bruker Avance III 300 MHz. 
 
Interestingly, phenol production has been mainly  reported in enteric bacteria [23]. Synthesis of 
phenol by those bacteria is carried out by the enzyme tyrosine-phenol-lyase (TPL) [24–26] and is 
directly  linked  to  the  availability  of  L-tyrosine.  To  assess  whether  the  production  of  phenol  by 
Pseudovibrio sp. D323 correlated with the presence of L-tyrosine, TLC analysis of the spent medium 
of the strain grown in the presence and absence of L-tyrosine was performed. Trace amounts of phenol 
were observed in the crude ethylacetate extract of Pseudovibrio sp. D323 grown in MMM, whereas 
phenol  production  was  greatly  enhanced  in  the  presence  of  L-tyrosine  (data  not  shown).  This  is 
suggestive of a similar pathway for phenol biosynthesis in Pseudovibrio sp. D323 as has been reported 
for enteric bacteria.  
The precise role of phenol production and secretion by Pseudovibrio sp. D323 and related bacteria 
is not clear. Despite being a known disinfectant, phenol, even at concentration of 1 mg/mL, did not 
have antibacterial activity in our assays. It is possible, however, that phenol may be used by the host as 
a precursor for the synthesis of yet other phenolic-based defence compounds common in many marine 
sponges and algae [27–31]. 
2.3. TDA Inhibits a Variety of Marine Bacteria but Shows No Auto-Inhibition in Producer Strains 
In  order  to  assess  the  inhibitory  spectrum  of  TDA  against  a  variety  of  relevant  environmental 
strains, disc diffusion assays [32], using a concentration of 0.1 mg/mL TDA, were performed against a 
collection of marine strains, including various D. pulchra associated bacteria. TDA inhibited a wide 
range of strains, including isolates belonging to all major phyla found on marine living surfaces, such 
as the Proteobacteria, Actinobacteria, Firmicutes and Bacteroidetes (Table 1). These results differ 
from an earlier study [19], which observed a phylogenetic bias with respect to the sensitivity to TDA 
of isolates from the German Wadden sea. Specifically, in that study Gammaproteobactera, were found 
to be mostly resistant to TDA [19], while our results show that bacteria from this class were among the 
most sensitive. To date nothing is known about the mode of action of TDA and it is, therefore, possible 
that differences of the target isolate at the level of genera and species may cause the observed differences. 
It  is  interesting  that  the  only  strains  found  to  be  resistant  to  the  inhibitory  effect  of  TDA  are  
TDA-producers themselves, including strain D323, P. inhibens, and the P. gallaeciensis strains 2.10 
C  
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2   120.3  120.0  
3   167.9  168.1  
4   150.9  150.2  
5   134.2 (
1H, 5.41, d, J = 8.9)  133.4 (1H, 5.38, d, J = 8.9) 
6   138.0 (
1H, 5.94, dd, J = 12.24)  137.3 (1H, 5.90, dd, J = 12.2) 
7   138.1 (
1H, 6.72, d, J = 12.21)  137.5 (1H, 6.63, d, J = 12.2) 
8   170.9  170.6  
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and BS107 [19]. Bruhn et al. [33] also observed Roseobacter clade strains to be TDA-resistant whilst 
all  non-Roseobacter  strains  tested  were  sensitive  to  TDA  produced  by  Ruegeria  sp.  (formerly 
Silicibacter) TM1040 [34]. Together these observations suggest that TDA producers may possess an 
efficient  resistance  mechanism  to  prevent  auto-inhibition.  Notably,  the  TDA-deficient  mutant  of  
P. inhibens, T5-3, still maintains this resistance characteristic (Table 1). 
Table 1. Inhibitory activity of TDA (0.1 mg/mL in methanol) produced by isolate D323 
against various marine bacteria as tested using the disc-diffusion method. 
Target Strains  Phylum  Origin 
Inhibition 
by TDA 
Alpha-proteobacterium D323 ^  Alphaproteobacteria  seaweed Delisea pulchra  - 
Phaeobacter inhibens T5 ^  Alphaproteobacteria  marine sediment  - 
Phaeobacter inhibens T5-3  Alphaproteobacteria  marine sediment  - 
Nautella sp. R11  Alphaproteobacteria  seaweed Delisea pulchra  +++ 
Phaeobacter gallaeciensis 2.10 ^  Alphaproteobacteria  seaweed Ulva lactuca  - 
Oceanicola granulosus   Alphaproteobacteria  seawater  ++ 
Oceanicola batsensis   Alphaproteobacteria  seawater  +++ 
Roseovarius sp. 2601  Alphaproteobacteria  seawater  ++ 
Oceanicaulis alexandrii   Alphaproteobacteria  seawater  ++ 
Rhodobacterales bacterium   Alphaproteobacteria  seawater  +++ 
Phaeobacter gallaeciensis BS107 ^  Alphaproteobacteria  scallop Pecten maximus  - 
Vibrio harveyi  Gammaproteobacteria  seawater   +++ 
Pseudoalteromonas tunicata  Gammaproteobacteria  tunicate Ciona intestinalis  +++ 
Pseudoalteromonas undina  Gammaproteobacteria  seawater  ++ 
Pseudoalteromonas piscicida  Gammaproteobacteria  dead fish  + 
Pseudoalteromonas citrea  Gammaproteobacteria  seawater  ++ 
Pseudoalteromonas haloplanktis  Gammaproteobacteria  oyster Crassostrea gigas  ++ 
Pseudoalteromonas ulvae  Gammaproteobacteria  seaweed Ulva lactuca  ++ 
Pseudoalteromonas flavipulchra   Gammaproteobacteria  seawater   + 
Acinetobacter sp. ESS07  Gammaproteobacteria  seaweed Delisea pulchra  +++ 
Marinomonas sp. ND73  Gammaproteobacteria  seaweed Delisea pulchra  +++ 
Shewanella sp. ND51  Gammaproteobacteria  seaweed Delisea pulchra  ++ 
Thalassomonas sp. ND29  Gammaproteobacteria  seaweed Delisea pulchra  +++ 
Thalassomonas sp. ND49  Gammaproteobacteria  seaweed Delisea pulchra  ++ 
Aestuariibacter sp. ND16  Gammaproteobacteria  seaweed Delisea pulchra  ++ 
Vibrio sp. ND23  Gammaproteobacteria  seaweed Delisea pulchra  ++ 
Dokdonia sp. ESS16  Bacteroidetes  seaweed Delisea pulchra  ++ 
Aquimarina sp. ND19  Bacteroidetes  seaweed Delisea pulchra  + 
Tenacibaculum sp. ND71  Bacteroidetes  seaweed Delisea pulchra  + 
Bacillus sp. D203  Firmicutes  seaweed Delisea pulchra  ++ 
Bacillus sp. ESS03  Firmicutes  seaweed Delisea pulchra  +++ 
Micrococcus sp. ESS26  Actinobacteria  seaweed Delisea pulchra  ++ 
Agrococcus sp. LSS27  Actinobacteria  seaweed Delisea pulchra  ++ 
+ zone of clearance in disc diffusion up to 3 mm from the edge of the disc; ++ 3–5 mm; +++ more 
than 5 mm; - no inhibition observed; ^ TDA-producing bacteria. Mar. Drugs 2011, 9  
 
 
1398 
The wide activity spectrum of activity of TDA suggests that its production can serve as a defence 
against competitive bacteria, and, hence, could protect the host against other surface colonisers. Notably, 
TDA was shown to be highly active against Nautella sp. R11 (formally Ruegeria sp. R11) (Table 1), 
which causes a bleaching disease in D. pulchra [35]. The observation of Webster et al. [15] that the 
loss  of  the  TDA-producer  NW001  coincides  with  heavy  microbial  colonisation  of  the  sponge, 
subsequently leading to its death, may also support this proposition. Whether TDA is produced in 
sufficient quantities in the natural environment to be able to protect the eukaryotic host as well as 
producer microorganisms from other potentially pathogenic colonizers remains to be a subject for  
a future study. 
3. Experimental Section  
3.1. Bacterial Strains and Culture Conditions 
Isolate D323 was obtained from the surface of the red alga Delisea pulchra [6]. Isolates CCSH21 
and CCSH24 are from the surface of the temperate sponge Cymbastela concentrica [36] located in 
coastal  waters  near  Sydney,  Australia.  The  Alphaproteobacterium  NW001  was  isolated  from  the 
tropical sponge Rhopaloeides odorabile [8] from the Great Barrier Reef. Phaeobacter inhibens T5 was 
isolated from marine sediment in Wadden Sea, Germany and P. inhibens T5-3 is a TDA deficient 
spontaneous mutant of T5 [19]. All strains were grown routinely in Marine Broth (MB, Difco 2216) 
shaking at ambient room temperature. 
3.2. 16S rRNA Gene Sequencing and Analysis 
To  determine  the  phylogenetic  relationship  among  D323-related  strains,  the  near-full-length  
16S  rRNA  gene  sequence  of  D323  was  obtained  using  standard  procedures  [6]  with  the  
following  universal  primers:  F27  (5′-GAGTTTGATCCTGGCTCAG-3′)  [37],  R1492  
(5′-ACGGTTACCTTGTTACGACTT-3′)  [38],  F530  (5′-GTGCCATC-CAGCCGCGG-3′)  and  R903 
(5′-CCGTCAATTCCTTTRAGTTT-3′) [39]. The consensus 16S rRNA gene sequence was used for 
the  phylogenetic  comparisons  and  a  maximum  likelihood  tree  was  constructed  using  the  ARB 
software [40]. 
3.3. Antibacterial Assays and Preparation of Crude Antibacterial Extracts  
Antibacterial assays were performed using a disc diffusion method [32] with Neisseria canis OH73 
as a target strain due to its high sensitivity to strain D323 [6]. 
To prepare initial antibacterial crude extracts from strain D323 and related bacterial strains, cultures 
were grown in MB to stationary phase. Spent medium was then collected and acidified to pH 2 using 
hydrochloric acid followed by extraction with ethylacetate. To assess the impact of L-tyrosine on the 
production  of  phenol,  strain  D323  was  grown  in  marine  minimal  medium  (MMM)  [41]  with  
and  without  the  addition  of  L-tyrosine  (0.9  mM)  prior  to  extraction  of  the  spent  medium  as 
described above. Mar. Drugs 2011, 9  
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3.4. Gas-Chromatography Mass-Spectrometry (GC-MS) 
The antibacterial crude extract was analysed by GC-MS using a 5890 series II gas chromatograph 
(Hewlett  Packard),  with  a  DB5  30  m  ×  0.32  mm  (internal  diameter)  ×  250  mm  (film  thickness) 
column, coupled to a 5972A mass-spectrometer (Hewlett Packard). The inlet temperature was set at 
250 °C; with a split ratio of 50:1. The GC oven was operated at an initial temperature of 50 °C for 
1 min and then increased to 200 °C at a rate of 20 °C/min. The transfer line temperature was set to 
250 °C. Data were collected from m/z 45 to 105. 
3.5. Thin Layer Chromatography (TLC) and TLC-Bioautography Overlay Assay (TLC-BOA) 
Crude extracts were spotted on TLC plates (Merck, silica gel 60 F254) in duplicate, along with 
relevant standards and media controls. The TLC plates were developed in ethylacetate:hexane (5:1) 
mixture, air-dried and stained in iodine vapour for 5 min to visualise sample spots. The duplicate plates 
were used for the TLC-BOA [42], in which after the development the TLC plate was overlayed with 
soft Luria Bertani (LB) agar containing 0.01% (w/v), 2,3,5-triphenyl-tetrazolium chloride (TTC, Sigma), 
and inoculated with a 5% (v/v) overnight culture of the target strain N. canis OH73. The overlayed 
plate was incubated at 37 °C overnight. Antibacterial activity was observed as a transparent halo on a 
red stained background that was indicative of bacterial growth.  
3.6. Purification of the Antibacterial Compound 
Initial purification of the active antibacterial compound was performed via solid phase extraction 
using prepacked cartridges (Silica, 10 g, 60 mL, Alltech). Five fractions (F1–F5) were eluted with an 
ethylacetate:hexane mixture, increasing the ratio of ethylacetate from 5:1 to a 10:1. The final eluate 
fraction (F6) was obtained with 100% methanol. 
Further purification and subsequent chemical analysis of the active fraction using LC-MS and NMR 
is described in the supplementary material. 
4. Conclusions  
This study has demonstrated both phenol and TDA production in Pseudovibrio sp. D323 and related 
strains, the latter being responsible for the antibacterial activity of these bacteria. The wide activity 
spectrum of TDA against various bacteria, including common marine epibionts, indicates that TDA 
could be used by Pseudovibrio sp. D323 and related organisms to defend themselves against other 
competitors. The frequent isolation of Pseudovibrio sp. D323 from marine sessile eukaryotic hosts also 
indicates a role for these bacteria in the defence of the eukaryotic host against heavy colonisation. 
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